Repository logo
 

Inducible and Deterministic Forward Programming of Human Pluripotent Stem Cells into Neurons, Skeletal Myocytes, and Oligodendrocytes

Published version
Peer-reviewed

Type

Article

Change log

Authors

Pawlowski, M 
Ortmann, D 
Bertero, A 
Tavares, JM 
Pedersen, RA 

Abstract

The isolation or in vitro derivation of many human cell types remains challenging and inefficient. Direct conversion of human pluripotent stem cells (hPSCs) by forced expression of transcription factors provides a potential alternative. However, deficient inducible gene expression in hPSCs has compromised efficiencies of forward programming approaches. We have systematically optimized inducible gene expression in hPSCs using a dual genomic safe harbor gene-targeting strategy. This approach provides a powerful platform for the generation of human cell types by forward programming. We report robust and deterministic reprogramming of hPSCs into neurons and functional skeletal myocytes. Finally, we present a forward programming strategy for rapid and highly efficient generation of human oligodendrocytes.

Description

Keywords

human pluripotent stem cells, neurons, oligodendrocyte progenitor cells, reprogramming, skeletal myocytes

Journal Title

Stem Cell Reports

Conference Name

Journal ISSN

2213-6711
2213-6711

Volume Title

8

Publisher

Elsevier (Cell Press)
Sponsorship
Medical Research Council (G0600275)
Medical Research Council (G0800784)
Medical Research Council (G1000847)
Medical Research Council (MC_PC_12009)
British Heart Foundation (None)
Research in the senior author’s laboratory is supported by a core support grant from the Wellcome Trust and MRC to the Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute. Further support was provided by a research fellowship from the German Research Foundation ( DFG PA2369/1-1 to M.P.), a British Heart Foundation PhD Studentship ( FS/11/77/39327 to A.B.), a Clinician Scientist Award from the National Institute for Health Research UK ( CS-2015-15-023 to M.R.N.K.), and the Qatar Foundation (to M.R.N.K.). The Wellcome Trust – Medical Research Council Cambridge Stem Cell Institute is supported by core funding from the Wellcome Trust and MRC.